| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 25,811 | 25,550 | 26,146 | 25,826 | | Cost of Revenue | 9,102 | 9,743 | 10,042 | 10,440 | | | Gross Profit | 16,709 | 15,807 | 16,104 | 15,386 | | | Operating Expenses | | Research Development | 4,222 | 4,142 | 4,346 | 4,606 | | Selling General and Administrative | 10,631 | 10,379 | 9,087 | 10,691 | | Non Recurring | (37) | 287 | 252 |
-
| | Others | 634 | 635 | 634 | 635 | | | | Total Operating Expenses | 15,450 | 15,443 | 14,319 |
-
| | | | Operating Income or Loss | 1,259 | 364 | 1,785 | (546) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (22) | (326) | (29) | 329 | | Earnings Before Interest And Taxes | 1,237 | 38 | 1,756 | (217) | | Interest Expense | 3 | 4 | 6 | 11 | | Income Before Tax | 1,234 | 34 | 1,750 | (228) | | Income Tax Expense | 214 | 1,155 | 415 | 127 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,020 | (1,121) | 1,335 | (355) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,020 | (1,121) | 1,335 | (355) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,020 | ($1,121) | $1,335 | ($355) |
|
0.51% Nasdaq 
0.01 (0.24%) 
Income Statement
